Generate a tailored SOP for Dr. Michael Zalutsky. Improve your application with a focused, well-structured draft.
Michael Rod Zalutsky is a distinguished professor in the field of radiology with a focus on neuro oncology, biomedical engineering, pathology, and radiation oncology at Duke University. His research primarily centers on the development of novel radioactive compounds aimed at improving diagnosis and treatment of cancer. Zalutsky has pioneered site-specific radiohalogenation of biomolecules and is known for his work with radionuclides such as iodine-123, iodine-124, and fluorine-18 for imaging and therapy. He is particularly interested in the applications of astatine-211, an alpha-emitting radionuclide, which shows promise in high cytotoxicity for targeted cancer therapy. Key achievements include the development of reagents for radioiodination that enhance therapeutic effects, and successful treatment methods demonstrated in preclinical rat models. His extensive publication record reflects a commitment to advancing nuclear medicine and targeted radiotherapeutics.
Duke University • Durham, NC
Professor of Radiology, focusing on neuro oncology and targeted radiotherapy.
Department of Biomedical Engineering (MS program)